Nymox Pharmaceutical
NYMX
#10580
Rank
โ‚น1.76 B
Marketcap
Country
โ‚น19.31
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -โ‚น4.92

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น5.79. In 2022 the company made an earnings per share (EPS) of -โ‚น7.72 an increase over its 2021 EPS that were of -โ‚น14.48.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น4.92-36.32%
2022-โ‚น7.72-46.67%
2021-โ‚น14.48-11.76%
2020-โ‚น16.41-15%
2019-โ‚น19.315.26%
2018-โ‚น18.35-26.92%
2017-โ‚น25.10-7.14%
2016-โ‚น27.04-40.43%
2015-โ‚น45.38291.67%
2014-โ‚น11.59-7.69%
2013-โ‚น12.55-43.48%
2012-โ‚น22.21-25.81%
2011-โ‚น29.9355%
2010-โ‚น19.3125%
2009-โ‚น15.450.08%
2008-โ‚น15.44-11.12%
2007-โ‚น17.37-0.16%
2006-โ‚น17.4028.59%
2005-โ‚น13.53-12.49%
2004-โ‚น15.46-16.05%
2003-โ‚น18.4219.07%
2002-โ‚น15.4714.45%
2001-โ‚น13.51-22.16%
2000-โ‚น17.365.64%
1999-โ‚น16.43-34.59%
1998-โ‚น25.12-3.6%
1997-โ‚น26.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น843.38-14,657.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น126.49-2,283.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น348.43-6,114.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,725-47,142.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น885.41-15,383.33%๐Ÿ‡บ๐Ÿ‡ธ USA